Therefore, from the perspective of the impact of asparaginase withdrawal on haematological tumour relapse, for children with intermediate and high-risk ALL, the potential dangers of being re-exposed to asparaginase must be carefully weighed against the need for asparaginase to ensure survival. Here, ASPG is linked to acute lymphoblastic leukemia.